Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland
- 13 February 2007
- journal article
- Published by Wiley in Developmental Medicine and Child Neurology
- Vol. 48 (6) , 495-499
- https://doi.org/10.1111/j.1469-8749.2006.tb01302.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- NovelTSC2 mutations and decreased expression of tuberin in cultured tumor cells with an insertion mutationHuman Mutation, 2004
- The Tuberous Sclerosis Complex and its Highly Variable ManifestationsJournal of Urology, 2003
- Lymphangioleiomyomatosis: a review of the literatureRespiratory Medicine, 2002
- Tuberous sclerosis complex: a review of neurological aspectsEuropean Journal of Paediatric Neurology, 2002
- Prevalence and Clinical Characteristics of Lymphangioleiomyomatosis (LAM) in Patients with Tuberous Sclerosis ComplexAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Pathogenesis of multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis and association with tuberous sclerosis genesTSC1andTSC2Pathology International, 2001
- Mutations in the tuberous sclerosis complex geneTSC2are a cause of sporadic pulmonary lymphangioleiomyomatosisProceedings of the National Academy of Sciences, 2000
- Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosisJournal of Medical Genetics, 2000
- Tuberous Sclerosis Complex Consensus Conference: Revised Clinical Diagnostic CriteriaJournal of Child Neurology, 1998
- Evidence That Lymphangiomyomatosis Is Caused by TSC2 Mutations: Chromosome 16p13 Loss of Heterozygosity in Angiomyolipomas and Lymph Nodes from Women with LymphangiomyomatosisAmerican Journal of Human Genetics, 1998